Eir Partners, a Miami, FL-based middle market private equity firm focused on healthcare technology and tech-enabled services, announced the final closing of Eir Partners Investment Program II with $496M in capital commitments.
The program secured commitments from a diversified range of investors including financial institutions, insurance companies, family offices, funds-of-funds, endowments and foundations, and seasoned industry executives.
Eir Partners Investment Program II will continue to invest in companies that have proven market fit and scale demonstrating outsized organic growth potential coupled with accretive M&A opportunities. The firm seeks to partner with businesses where its operating experience and executive advisor network can make an impact across all aspects of the business including technology, finance, sales, and human capital.
Eir Partners Capital is a private equity firm focused exclusively on healthcare technology and tech- enabled services. Targeted stages of investment include growth equity through control buyouts and equity check sizes range from $25 – $100 million. Since inception, the firm has completed transactions across payer, provider, employer and pharma tech, including leading industry names such as Apixio, Capta, GiftHealth, Helpware, and ReviveHealth.
Eir previously raised $255M in capital commitments for its inaugural program, Eir Partners Program I, which closed in 2021 and invested in five platform investments.
FinSMEs
21/05/2024